InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Ware Olivia C, 董事. Insider active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 7 reports have been published. History available since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ware Olivia C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
16,675 股@ US$3.65100.0% 占其流量Common StockSEC:0000950170-25-015354:0
15,000 股0Common StockSEC:0001479290-24-000090:0
9,402 股@ US$7.6151.7% 占其流量Common StockSEC:0001415889-24-011120:0
9,000 股@ US$7.6148.3% 占其流量Common StockSEC:0001415889-24-008340:0
3,534 股0Common StockSEC:0001479290-23-000063:0
6,059 股0Common StockSEC:0001479290-22-000058:0
674 股0Common StockSEC:0001479290-21-000118:0
7 条申报中的 7 条
About Ware Olivia C
Olivia C. Ware serves as a Director of Revance Therapeutics, Inc. In this role, she participates in the governance of the company and in making strategic decisions. Her experience in the biopharmaceutical sector is an asset for Revance in its innovation efforts.
